AKTS Key Statistics, Chart & Performance
The current stock price of AKTS is 22.4 USD. In the past month the price decreased by -53.85%. In the past year, price decreased by -95.57%.
AKTS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| APH | AMPHENOL CORP-CL A | 48 | 171.56B | ||
| GLW | CORNING INC | 35.81 | 73.07B | ||
| COHR | COHERENT CORP | 44.29 | 27.98B | ||
| LFUS | LITTELFUSE INC | 27.76 | 6.93B | ||
| BDC | BELDEN INC | 15.46 | 4.48B | ||
| BELFB | BEL FUSE INC-CL B | 28.23 | 2.37B | ||
| VSH | VISHAY INTERTECHNOLOGY INC | 809.5 | 2.20B | ||
| BELFA | BEL FUSE INC-CL A | 25.32 | 2.13B | ||
| KN | KNOWLES CORP | 22.68 | 1.97B | ||
| ROG | ROGERS CORP | 48.59 | 1.72B | ||
| LWLG | LIGHTWAVE LOGIC INC | N/A | 554.56M | ||
| MPTI | M-TRON INDUSTRIES INC | 26.43 | 189.72M |
Related stock screener links
About AKTS
Company Profile
Akoustis Technologies, Inc. is a filter solutions company, which engages in the development, design, and manufacture of radio frequency (RF) filter products. The company is headquartered in Huntersville, North Carolina and currently employs 117 full-time employees. The company went IPO on 2017-03-13. The firm has developed a microelectromechanical system (MEMS) based BAW technology and a manufacturing process flow, called XBAW, for its filters produced for use in RF front-end modules. Its XBAW filters incorporate optimized high purity piezoelectric materials for high power, high frequency and wide bandwidth operation. The company is developing RF Filters for 5G, Wi-Fi and defense bands using its resonator device models and product design kits. The firm provides solutions for the wireless industry, including for products such as smartphones and tablets, network infrastructure equipment, Wi-Fi Customer Premise Equipment, and defense applications. Its segments include Fabrication Services and RF Filters. Fabrication Services segment consists of engineering review services and backend packaging services. RF Filters segment consists of amplifier and filter product sales.
Company Info
AKTIS ONCOLOGY INC
9805 Northcross Center Ct Ste A
Huntersville NORTH CAROLINA 28078 US
CEO: Jeffrey B. Shealy
Employees: 222
Phone: 17026054086
AKTIS ONCOLOGY INC / AKTS FAQ
What does AKTIS ONCOLOGY INC do?
Akoustis Technologies, Inc. is a filter solutions company, which engages in the development, design, and manufacture of radio frequency (RF) filter products. The company is headquartered in Huntersville, North Carolina and currently employs 117 full-time employees. The company went IPO on 2017-03-13. The firm has developed a microelectromechanical system (MEMS) based BAW technology and a manufacturing process flow, called XBAW, for its filters produced for use in RF front-end modules. Its XBAW filters incorporate optimized high purity piezoelectric materials for high power, high frequency and wide bandwidth operation. The company is developing RF Filters for 5G, Wi-Fi and defense bands using its resonator device models and product design kits. The firm provides solutions for the wireless industry, including for products such as smartphones and tablets, network infrastructure equipment, Wi-Fi Customer Premise Equipment, and defense applications. Its segments include Fabrication Services and RF Filters. Fabrication Services segment consists of engineering review services and backend packaging services. RF Filters segment consists of amplifier and filter product sales.
What is the current price of AKTS stock?
The current stock price of AKTS is 22.4 USD. The price increased by 60115.05% in the last trading session.
Does AKTIS ONCOLOGY INC pay dividends?
AKTS does not pay a dividend.
How is the ChartMill rating for AKTIS ONCOLOGY INC?
AKTS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Where is AKTIS ONCOLOGY INC (AKTS) stock traded?
AKTS stock is listed on the Nasdaq exchange.
What do analysts say about AKTIS ONCOLOGY INC (AKTS) stock?
7 analysts have analysed AKTS and the average price target is 0.26 USD. This implies a price decrease of -98.86% is expected in the next year compared to the current price of 22.4.
What is the employee count for AKTS stock?
AKTIS ONCOLOGY INC (AKTS) currently has 222 employees.
AKTS Technical Analysis
AKTS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AKTS. AKTS has a bad profitability rating. Also its financial health evaluation is rather negative.
AKTS Financial Highlights
Over the last trailing twelve months AKTS reported a non-GAAP Earnings per Share(EPS) of -1.42. The EPS decreased by -49.48% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -268.85% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AKTS Forecast & Estimates
7 analysts have analysed AKTS and the average price target is 0.26 USD. This implies a price decrease of -98.86% is expected in the next year compared to the current price of 22.4.
For the next year, analysts expect an EPS growth of 42.58% and a revenue growth 29.7% for AKTS